W 56750
Alternative Names: W-56750Latest Information Update: 17 May 2016
At a glance
- Originator Mitsubishi Pharma Corporation
- Developer Mitsubishi Tanabe Pharma Corporation
- Class Small molecules
- Mechanism of Action CCR3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Allergic conjunctivitis; Atopic dermatitis
Most Recent Events
- 17 May 2016 Discontinued - Preclinical for Allergic conjunctivitis in Japan (PO)
- 17 May 2016 Discontinued - Preclinical for Atopic dermatitis in Japan (PO)